TIRAT CARMEL, ISRAEL, Sep 02, 2011 (MARKETWIRE via COMTEX) ?
D. Medical Industries Ltd.
/quotes/zigman/65487/quotes/nls/dmed DMED
+2.30%
(tase:DMED)(?D. Medical?
or the ?Company?), a medical device company engaged through its
subsidiaries in the research, development, manufacture and sale of
innovative products for diabetes treatment and drug delivery, today
announced that Amir Loberman, the Company?s Chief Financial Officer,
will present an update on the Company?s business at the Rodman
Renshaw Annual Global Investment Conference on Tuesday, September 13,
2011 at 4:30 p.m. Eastern Time. The conference is being held at the
Waldorf-Astoria hotel in New York City, NY.
Mr. Loberman?s presentation will be webcast live and archived for at
least 30 days on the Company?s website at
http://www.dmedicalindustries.com under the ?Webcasts? tab in the
Investors section.
About D. Medical
D. Medical is a medical device company engaged through its
subsidiaries in the research, development, manufacture and sale of
innovative products for diabetes treatment and drug delivery. D.
Medical has developed durable and semi-disposable insulin pumps,
which continuously infuse insulin into a patient?s body, using its
proprietary spring-based delivery technology. D. Medical believes
that its spring-based delivery mechanism is cost-effective compared
to the motor and gear train mechanisms that drive competitive insulin
pumps and also allows it to incorporate certain advantageous
functions and design features in its insulin pumps. D. Medical has
also developed an infusion set for insulin pumps and is focusing its
research and development efforts on the development of next
generation insulin pumps. For more information, please visit
http://www.dmedicalindustries.com (corporate) and
http://www.springnow.com (healthcare professionals, patients and
caregivers).
Forward-Looking Statements
This press release contains forward-looking statements (as defined by
the Israeli Securities Law, 1968, Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended) that involve risks and uncertainties. These
statements include, forecasts, goals, uncertainties and assumptions
and relate, inter alia, to D. Medical?s future expectations in
connection with its level of sales and cost of sales, manufacturing
volumes, the cost-effectiveness of its spring-based design, target
markets, regulatory approvals and timing of markets penetration. The
forward-looking statements are based on D. Medical?s current
expectations and beliefs which are based on, among other things, its
analysis of publicly available information and market research
reports. All forward-looking statements are subject to certain risks,
uncertainties and assumptions that could cause actual results to
differ materially from those described in the forward-looking
statements. Such risks and uncertainties include, but are not limited
to, the impact of general economic conditions, competitive products,
product demand, product performance, the performance of D. Medical?s
contract manufacturer and distributors, regulatory trends and
approvals and healthcare reform legislation. If one or more of these
risks and/or uncertainties materialize, or if the underlying
assumptions prove to be incorrect, D. Medical?s actual results,
performance or achievements could differ materially from those
expressed in, or implied by, any such forward-looking statements or
results which are based upon such assumptions. No assurances can be
given that any of the events anticipated by the forward-looking
statements will transpire or occur, or of any of them will transpire
or occur, what impact it will have on D. Medical?s results of
operations or financial condition. D. Medicals does not undertake to
update any forward-looking statements.
Contacts: Company Contact: D. Medical Industries LTD Amir Loberman Chief Financial Officer +972-73-2507100 info@springnow.com North American Investor Contact: Stephen Kilmer 212-618-6347 stephen@dmedicalindustries.com Israeli Investor Relations Iris Lubitch 972-775538007 Iris@EffectiveIR.co.il
SOURCE: D. Medical Industries Ltd.
mailto:info@springnow.com mailto:stephen@dmedicalindustries.com mailto:Iris@EffectiveIR.co.il
Copyright 2011 Marketwire, Inc., All rights reserved.
/quotes/zigman/65487/quotes/nls/dmed
Add DMED to portfolio
DMED
Article source: http://www.marketwatch.com/story/d-medical-to-present-at-the-rodman-renshaw-annual-global-investment-conference-2011-09-02?reflink=MW_news_stmp
Related posts:
- Southern Home Medical Achieves Seventh Consecutive Month of Profitability and ?
- ICU Medical, Inc. to Present at Two Investor Conferences in September
- Vycor Medical, Inc. Files Restated Financial Statements
- St. Jude Medical Begins U.S. Trial Studying ST Segment Monitoring Technology
- Symmetry Medical to Present at Two Upcoming Conferences
grocery coupons aladdin cma keith urban pro ana wasabi wasabi
No comments:
Post a Comment